The effect of add-on treatment with quetiapine on measures of depression, aggression, irritability and suicidal tendencies in children and adolescents

被引：5
作者：
Josip Podobnik
Iris Foller Podobnik
Neda Grgic
Darko Marcinko
Nela Pivac
机构：
[1] Psychiatric Hospital for Children and Youth Zagreb,Department of Psychiatry
[2] University Hospital Centre Zagreb,Department of Psychiatry
[3] School of Medicine,Division of Molecular Medicine
[4] University of Zagreb,undefined
[5] Rudjer Boskovic Institute,undefined
来源：
Psychopharmacology | 2012年 / 220卷 / 3期
关键词：
Bipolar Disorder; Borderline Personality Disorder; Eating Disorder; Quetiapine; Fluvoxamine;
D O I：
10.1007/s00213-011-2607-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：639 / 641
页数：2
相关论文
共 38 条
  • [1] Abraham PF(2008)Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics? J Affect Disord 111 21-30
  • [2] Calabrese JR(2008)Quetiapine in patients with borderline personality disorder: an open-label trial Ann Clin Psychiatry 20 219-226
  • [3] Adityanjee RA(2006)The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s) J Child Adolesc Psychopharmacol 16 665-670
  • [4] Brown E(2011)Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: a systematic review of randomized, placebo controlled trials and guidelines for clinical practice Eur Neuropsychopharmacol 21 144-158
  • [5] Thuras P(2009)A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder Bipolar Disord 11 483-493
  • [6] Lee S(2007)A 26-week open-label study of quetiapine in children with conduct disorder J Child Adolesc Psychopharmacol 17 1-9
  • [7] Schulz SC(2011)Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies Eur Neuropsychopharmacol 21 600-620
  • [8] Barzman DH(undefined)undefined undefined undefined undefined-undefined
  • [9] DelBello MP(undefined)undefined undefined undefined undefined-undefined
  • [10] Adler CM(undefined)undefined undefined undefined undefined-undefined
1234